Cytori Cell Research Institute, Inc. (3750.T)
JPY 916.0
(-1.51%)
JPY 916.0
(-1.51%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.29 Billion JPY | 1.86% |
| 2022 | 1.26 Billion JPY | 47.69% |
| 2021 | 859.23 Million JPY | 13.01% |
| 2020 | 760.32 Million JPY | 0.57% |
| 2019 | 756 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 20 Million JPY | -85.36% |
| 2023 Q2 | 327.01 Million JPY | -18.47% |
| 2023 Q1 | 401.09 Million JPY | 12.96% |
| 2023 Q4 | 136.64 Million JPY | -68.06% |
| 2023 Q3 | 427.86 Million JPY | 30.84% |
| 2023 FY | 1.29 Billion JPY | 1.86% |
| 2022 Q3 | 375.84 Million JPY | 46.88% |
| 2022 FY | 1.26 Billion JPY | 47.69% |
| 2022 Q4 | 355.07 Million JPY | -5.53% |
| 2022 Q2 | 255.89 Million JPY | 0.0% |
| 2021 FY | 859.23 Million JPY | 13.01% |
| 2020 FY | 760.32 Million JPY | 0.57% |
| 2019 FY | 756 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 31.291% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -1509.607% |
| GNI Group Ltd. | 22.43 Billion JPY | 94.237% |
| Linical Co., Ltd. | 3.77 Billion JPY | 65.788% |
| Trans Genic Inc. | 2.24 Billion JPY | 42.532% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -1215.608% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 47.928% |
| AnGes, Inc. | -3.06 Billion JPY | 142.169% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 827.338% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 86.624% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -149.88% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -1064.976% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 10.891% |
| CanBas Co., Ltd. | -984 Million JPY | 231.363% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -230.002% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 21.951% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -224.292% |
| Kidswell Bio Corporation | 1.03 Billion JPY | -24.363% |
| PeptiDream Inc. | 17.21 Billion JPY | 92.493% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -4123.529% |
| Ribomic Inc. | -10.5 Million JPY | 12408.237% |
| SanBio Company Limited | -14.5 Million JPY | 9012.1% |
| Healios K.K. | 108 Million JPY | -1096.862% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 379164.809% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 2289.159% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 85590.146% |
| StemRIM | -44.34 Million JPY | 3014.634% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 59.416% |
| FunPep Company Limited | -680.28 Million JPY | 290.01% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -1766.586% |
| Stella Pharma Corporation | 217.29 Million JPY | -494.856% |
| TMS Co., Ltd. | -6.95 Million JPY | 18698.719% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -310.925% |
| Cuorips Inc. | 9.63 Million JPY | -13321.358% |
| K Pharma,Inc. | 910 Million JPY | -42.045% |
| Takara Bio Inc. | 25.45 Billion JPY | 94.922% |
| ReproCELL Incorporated | 1.1 Billion JPY | -17.008% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | -8.163% |
| StemCell Institute Inc. | 1.57 Billion JPY | 17.975% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 22.449% |
| CellSeed Inc. | 107.15 Million JPY | -1106.3% |